Cargando…

Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer

BACKGROUND: Ovarian cancer (OC) is one of the most frequently seen and fatal gynecological malignancies, and oxidative stress (OS) plays a critical role in the development and chemoresistance of OC. MATERIALS AND METHODS: OS-related genes (OSRGs) were obtained from the Molecular Signatures Database....

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qingyang, Yang, Xiaocheng, Yin, Yuhan, Zhang, Hao, Yin, Fanxing, Guo, Panpan, Zhang, Xiaoxu, Sun, Chenxi, Li, Shining, Han, Yanshuo, Yang, Zhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764017/ https://www.ncbi.nlm.nih.gov/pubmed/36561981 http://dx.doi.org/10.1155/2022/6575534

Ejemplares similares

Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer
por: Liu, Qingyang, et al.
Publicado: (2022)

Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer
por: Yang, Xiaocheng, et al.
Publicado: (2022)

Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis
por: Song, Xiaotong, et al.
Publicado: (2021)

N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through YTHDF3 Modulating Macrophage Polarization
por: Wu, Yihao, et al.
Publicado: (2022)

The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection
por: Yin, Fanxing, et al.
Publicado: (2023)

CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction
por: Guo, Xu, et al.
Publicado: (2022)

Construction of the circRNA-miRNA-mRNA Regulatory Network of an Abdominal Aortic Aneurysm to Explore Its Potential Pathogenesis
por: Zhang, Hao, et al.
Publicado: (2021)

Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in human aortic dissection
por: Zhang, Hao, et al.
Publicado: (2021)

Establishment, immunological analysis, and drug prediction of a prognostic signature of ovarian cancer related to histone acetylation
por: Fang, Yujie, et al.
Publicado: (2022)

Comprehensive Analysis of Key m6A Modification Related Genes and Immune Infiltrates in Human Aortic Dissection
por: Yin, Fanxing, et al.
Publicado: (2022)

Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
por: Mo, Qianxing, et al.
Publicado: (2020)

DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
por: Liu, Nanbin, et al.
Publicado: (2023)

Application Of Adoptive Immunotherapy In Ovarian Cancer
por: Yang, Siyu, et al.
Publicado: (2019)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
por: Khandakar, Binny, et al.
Publicado: (2014)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)

Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
por: Mei, Jie, et al.
Publicado: (2023)

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer
por: Li, Chanyuan, et al.
Publicado: (2023)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
por: Ao, Huang, et al.
Publicado: (2021)

Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy
por: Zheng, Yushi, et al.
Publicado: (2023)

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
por: Fan, Lijun, et al.
Publicado: (2016)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022)

SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment
por: Zhu, Ying, et al.
Publicado: (2021)

Identifying Mitotic Kinesins as Potential Prognostic Biomarkers in Ovarian Cancer Using Bioinformatic Analyses
por: Liu, Hailun, et al.
Publicado: (2022)

A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer
por: Zhu, Huijun, et al.
Publicado: (2021)

A novel immune-related prognostic signature in epithelial ovarian carcinoma
por: Su, Tong, et al.
Publicado: (2021)

Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)

TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer
por: Liu, T, et al.
Publicado: (2013)

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
por: Shi, Junhong, et al.
Publicado: (2021)

Postoperative chemotherapy had no prognostic effect on early‐staged young ovarian cancer with unilateral resection
por: Zhang, Xiaofei, et al.
Publicado: (2018)

Comprehensive network analysis of dysregulated genes revealed MNX1‐AS1/hsa‐miR‐4697‐3p/HOXB13 axis in ovarian cancer chemotherapy response
por: Wu, Anqi, et al.
Publicado: (2022)

Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma
por: Liang, Qiuli, et al.
Publicado: (2021)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2fj1abjk82ah38hr9kccd9obhf